Anti-IL-23 (Tremfya)(Guselkumab biosimilar) mAb
Order now and get it on Tuesday May 30, 2023
Same day delivery FREE on San Diego area orders placed by 1.00 PM
|Amount :||100 µg|
|Purification :||Purified from cell culture supernatant by affinity chromatography|
|Storage condition :||Store at -20°C to -80°C (Avoid repeated freezing and thawing).|
Tremfya or Guselkumab biosimilar is human immunoglobulin G1 lambda (IgG1lambda) monoclonal antibody, a member of the interleukin inhibitors that selectively block interleukin-23 p19. It usually is important in the treatment of Psoriasis. IL-23 is an inflammatory cytokine responsible for the induction of psoriatic plaque formation. It activates the CD4+ T-helper (Th17) cell pathway. Guselkumab biosimilar developed by Abeomics is for research use only and should not be used in diagnostic procedures.
ELISA 1:5000-10000, FACS 1:100
For Research Use Only. Not for use in diagnostic/therapeutics procedures.
There are currently no product reviews